Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
A randomized, placebo-controlled pilot study to determine endoscopic recurrence of Crohn's
disease 12 months after curative, resective ileal or ileocolonic surgery in patients
receiving post-operative infliximab or placebo